Partner at Smart & Biggar
Daphne Lainson is a partner in Smart & Biggar’s Ottawa office. She specialises in securing patent protection for chemical, pharmaceutical and biotechnology-related inventions. She is a qualified lawyer and patent and trademark agent and has an advanced degree in chemistry. She has been helping clients secure patent protection for their innovations for almost two decades and plays a leading role in client relations management within the firm, particularly in key industrial markets such as the United States, Japan and Germany.
Ms Lainson champions and safeguards clients’ IP rights, protecting their inventions in new drugs, biologics, medical devices, consumer products, agrochemicals, specialty chemicals, industrial chemical processes, oil, gas and petrochemicals. She also advises clients on pharmaceutical regulatory law. This includes providing strategic advice during patent prosecution and following patent grant for both pharmaceuticals and biologics. She is called on to advise innovative pharmaceutical and biopharmaceutical companies in matters relating to regulatory data exclusivity under the Food and Drug Regulations, patent listing and enforcement under the Patented Medicines (Notice of Compliance) Regulations, certificates of supplementary protection (CSPs) under the CSP Regulations and market access issues, including those relating to the Patented Medicine Prices Review Board.
Ms Lainson was recognised in the 2017 edition of Euromoney’s Expert Guides: Women in Business Law as a top legal practitioner in patents. She is named annually as a World IP Review Leader and has been recognised by Best Lawyers in Canada for IP and biotechnology law. In 2012 she was listed as one of Canada’s Rising Stars: Leading Lawyers Under 40 by Lexpert and in 2011 she was named Ottawa Businesswoman of the Year in the professional category by the Women’s Business Network of Ottawa.
Ms Lainson is a fellow of the American Intellectual Property Law Association (AIPLA) and chair of the AIPLA Food and Drug Law Committee.